Professionals Services Insights Community

About Offices Careers

Professionals Services Insights Community

About Offices Careers

Home / Insights / Protecting deuterated drugs ...

PDF

02/01/2018 | Intellectual Property Magazine

Erin J.D. Austin

Protecting deuterated drugs

1 min

With companies paying substantial sums for marketing rights over deuterated drugs, Michael Furrow and Erin Austin examine critical patent strategies and considerations.

View full PDF

Related Services

Practices

Pharmaceuticals
Intellectual Property
Intellectual Property Litigation

Related Insights

Longer Holds, Hidden Value: Five IP Questions Private Equity Sponsors Should Ask

October 23, 2026

4min

You Built a Coffee Brand—Great, Now How Do You Protect It?

October 16, 2026

2min

AI Agents, Data, and the Future of Legal Practice

October 14, 2026

1min

Events

Skinny Labels and Beyond: How the Same Pharmaceutical Patent Can Yield Different Outcomes — And What Recent International High Court Rulings Mean for Your Global Strategy

October 27, 2026 New York, NY - Venable LLP

SupplySide Global 2026

October 28 - 30, 2026 Las Vegas, NV - SupplySide Global

IP Strategy: The Roadmap to a Smarter Future

December 04, 2026

Recent News

Ariel Wolf to Receive ASIRT Road Safety Champion Award on November 12

November 12, 2026

1min

Venable Attorneys Named to Baltimore Magazine’s 2026 Top Lawyers List

October 19, 2026

1min

Sports Litigation Alert Features Paul Levin and Randi Rubinstein in a Q&A on Future Earning Agreements for Athletes

October 16, 2026

2min

Subscribe Careers About News Offices